{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:32:42Z","timestamp":1774816362854,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Liver fibrosis (LF) is a common pathological process characterized by the activation of hepatic stellate cells (HSCs) and accumulation of extracellular matrix. Severe LF causes cirrhosis and even liver failure, a major cause of morbidity and mortality worldwide. Transplantation of human placental mesenchymal stem cells (hPMSCs) has been considered as an alternative therapy. However, the underlying mechanisms and the appropriate time window for hPMSC transplantation are not well understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We established mouse models of CCl<jats:sub>4<\/jats:sub>-injured LF and administered hPMSCs at different stages of LF once a week for 2 weeks. The therapeutic effect of hPMSCs on LF was investigated, according to histopathological and blood biochemical analyses. In vitro, the effect of hPMSCs and the secretomes of hPMSCs on the inhibition of activated HSCs was assessed. RNA sequencing (RNA-seq) analysis, real-time PCR array, and western blot were performed to explore possible signaling pathways involved in treatment of LF with hPMSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>hPMSC treatment notably alleviates experimental hepatic fibrosis, restores liver function, and inhibits inflammation. Furthermore, the therapeutic effect of hPMSCs against mild-to-moderate LF was significantly greater than against severe LF. In vitro, we observed that the hPMSCs as well as the secretomes of hPMSCs were able to decrease the activation of HSCs. Mechanistic dissection studies showed that hPMSC treatment downregulated the expression of fibrosis-related genes, and this was accompanied by the upregulation of Caveolin-1 (Cav1) (<jats:italic>p<\/jats:italic> &lt; 0.001). This suggested that the amelioration of LF occurred partly due to the restoration of Cav1 expression in activated HSCs. Upregulation of <jats:italic>Cav1<\/jats:italic> can inhibit the TGF-\u03b2\/Smad signaling pathway, mainly by reducing Smad2 phosphorylation, resulting in the inhibition of activated HSCs, whereas this effect could be abated if <jats:italic>Cav1<\/jats:italic> was silenced in advance by siRNAs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that hPMSCs could provide multifaceted therapeutic benefits for the treatment of LF, and the TGF-\u03b2\/<jats:italic>Cav1<\/jats:italic> pathway might act as a therapeutic target for hPMSCs in the treatment of LF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02358-x","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T12:07:58Z","timestamp":1621512478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Yunqi","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhemin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-4493","authenticated-orcid":false,"given":"Hongxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"1","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37(1):1\u201310. https:\/\/doi.org\/10.1055\/s-0036-1597816.","journal-title":"Semin Liver Dis."},{"issue":"2","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","volume":"26","author":"S Tanwar","year":"2020","unstructured":"Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol. 2020;26(2):109\u201333. https:\/\/doi.org\/10.3748\/wjg.v26.i2.109.","journal-title":"World J Gastroenterol."},{"issue":"7","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2358_CR4","doi-asserted-by":"publisher","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8(11):1419. https:\/\/doi.org\/10.3390\/cells8111419.","DOI":"10.3390\/cells811141"},{"key":"2358_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355. https:\/\/doi.org\/10.1016\/j.mam.2018.09.002.","journal-title":"Mol Aspects Med."},{"issue":"8","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4252\/wjsc.v11.i8.548","volume":"11","author":"F Yin","year":"2019","unstructured":"Yin F, Wang WY, Jiang WH. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: from biological characteristics to therapeutic mechanisms. World J Stem Cells. 2019;11(8):548\u201364. https:\/\/doi.org\/10.4252\/wjsc.v11.i8.548.","journal-title":"World J Stem Cells."},{"issue":"1 Suppl","key":"2358_CR7","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1016\/j.jhep.2015.02.040","volume":"62","author":"SJ Forbes","year":"2015","unstructured":"Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol. 2015;62(1 Suppl):S157\u201369. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.040.","journal-title":"J Hepatol."},{"issue":"4","key":"2358_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.trsl.2014.01.005","volume":"163","author":"SA Mao","year":"2014","unstructured":"Mao SA, Glorioso JM, Nyberg SL. Liver regeneration. Transl Res. 2014;163(4):352\u201362. https:\/\/doi.org\/10.1016\/j.trsl.2014.01.005.","journal-title":"Transl Res."},{"issue":"1","key":"2358_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","volume":"39","author":"A Tsuchiya","year":"2019","unstructured":"Tsuchiya A, Takeuchi S, Watanabe T, Yoshida T, Nojiri S, Ogawa M, et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \u201cconducting cells\u201d for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39(1):18. https:\/\/doi.org\/10.1186\/s41232-019-0107-z.","journal-title":"Inflamm Regen."},{"issue":"8","key":"2358_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann Transl Med. 2020;8(8):562. https:\/\/doi.org\/10.21037\/atm.2020.02.119.","journal-title":"Ann Transl Med."},{"issue":"6","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","volume":"68","author":"M Alfaifi","year":"2018","unstructured":"Alfaifi M, Eom YW, Newsome PN, Baik SK. Mesenchymal stromal cell therapy for liver diseases. J Hepatol. 2018;68(6):1272\u201385. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.030.","journal-title":"J Hepatol."},{"issue":"3","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/jcmm.14115","volume":"23","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Duan J, Li L. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. J Cell Mol Med. 2019;23(3):1657\u201370. https:\/\/doi.org\/10.1111\/jcmm.14115.","journal-title":"J Cell Mol Med."},{"key":"2358_CR13","doi-asserted-by":"publisher","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784. https:\/\/doi.org\/10.3390\/cells8080784.","DOI":"10.3390\/cells8080784"},{"issue":"1","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4(1):22. https:\/\/doi.org\/10.1038\/s41536-019-0083-6.","journal-title":"NPJ Regen Med."},{"issue":"5","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","volume":"30","author":"YW Eom","year":"2015","unstructured":"Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med. 2015;30(5):580\u20139. https:\/\/doi.org\/10.3904\/kjim.2015.30.5.580.","journal-title":"Korean J Intern Med."},{"issue":"6","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, L\u00e4sser C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019;13(6):6670\u201388. https:\/\/doi.org\/10.1021\/acsnano.9b01004.","journal-title":"ACS Nano."},{"issue":"2","key":"2358_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00018-019-03268-1","volume":"77","author":"SA Mathew","year":"2020","unstructured":"Mathew SA, Naik C, Cahill PA, Bhonde RR. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis. Cell Mol Life Sci. 2020;77(2):253\u201365. https:\/\/doi.org\/10.1007\/s00018-019-03268-1.","journal-title":"Cell Mol Life Sci."},{"issue":"5","key":"2358_CR18","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.athoracsur.2012.11.053","volume":"95","author":"G Makhoul","year":"2013","unstructured":"Makhoul G, Chiu RC, Cecere R. Placental mesenchymal stem cells: a unique source for cellular cardiomyoplasty. Ann Thorac Surg. 2013;95(5):1827\u201333. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.11.053.","journal-title":"Ann Thorac Surg."},{"key":"2358_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.placenta.2017.04.003","volume":"59","author":"MH Abumaree","year":"2017","unstructured":"Abumaree MH, Abomaray FM, Alshabibi MA, AlAskar AS, Kalionis B. Immunomodulatory properties of human placental mesenchymal stem\/stromal cells. Placenta. 2017;59:87\u201395. https:\/\/doi.org\/10.1016\/j.placenta.2017.04.003.","journal-title":"Placenta."},{"issue":"1","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","volume":"37","author":"JS Heo","year":"2016","unstructured":"Heo JS, Choi Y, Kim HS, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37(1):115\u201325. https:\/\/doi.org\/10.3892\/ijmm.2015.2413.","journal-title":"Int J Mol Med."},{"issue":"1","key":"2358_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1741-7015-10-56","volume":"10","author":"H Cao","year":"2012","unstructured":"Cao H, Yang J, Yu J, Pan Q, Li J, Zhou P, et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med. 2012;10(1):56. https:\/\/doi.org\/10.1186\/1741-7015-10-56.","journal-title":"BMC Med."},{"issue":"8","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/stem.1396","volume":"31","author":"J Jung","year":"2013","unstructured":"Jung J, Choi JH, Lee Y, Park JW, Oh IH, Hwang SG, et al. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism. Stem Cells. 2013;31(8):1584\u201396. https:\/\/doi.org\/10.1002\/stem.1396.","journal-title":"Stem Cells."},{"issue":"12","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.7150\/thno.31951","volume":"9","author":"Z Feng","year":"2019","unstructured":"Feng Z, Wei Y, Zhang Y, Qiu Y, Liu X, Su L, et al. Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression. Theranostics. 2019;9(12):3501\u201314. https:\/\/doi.org\/10.7150\/thno.31951.","journal-title":"Theranostics."},{"issue":"6","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.cell.2019.07.021","volume":"178","author":"M Xu","year":"2019","unstructured":"Xu M, Xu HH, Lin Y, Sun X, Wang LJ, Fang ZP, et al. LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis. Cell. 2019;178(6):1478\u20131492.e20.","journal-title":"Cell"},{"issue":"5","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim HJ, Han J, Lee J, Lee G, et al. Milk Fat Globule-EGF Factor 8, Secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.003.","journal-title":"Gastroenterology."},{"issue":"10","key":"2358_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.5966\/sctm.2015-0353","volume":"5","author":"M Hirata","year":"2016","unstructured":"Hirata M, Ishigami M, Matsushita Y, Ito T, Hattori H, Hibi H, et al. Multifaceted therapeutic benefits of factors derived from dental pulp stem cells for mouse liver fibrosis. Stem Cells Transl Med. 2016;5(10):1416\u201324. https:\/\/doi.org\/10.5966\/sctm.2015-0353.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"2358_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen Y, Lambrecht J, Ju C, Tacke F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2021;18(1):45\u201356. https:\/\/doi.org\/10.1038\/s41423-020-00558-8.","journal-title":"Cell Mol Immunol."},{"key":"2358_CR28","doi-asserted-by":"publisher","unstructured":"Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852. https:\/\/doi.org\/10.3390\/ijms18091852.","DOI":"10.3390\/ijms18091852"},{"key":"2358_CR29","doi-asserted-by":"publisher","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8(5):467. https:\/\/doi.org\/10.3390\/cells8050467.","DOI":"10.3390\/cells8050467"},{"issue":"10","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.molmed.2016.08.007","volume":"22","author":"MA Fernandez-Rojo","year":"2016","unstructured":"Fernandez-Rojo MA, Ramm GA. Caveolin-1 function in liver physiology and disease. Trends Mol Med. 2016;22(10):889\u2013904. https:\/\/doi.org\/10.1016\/j.molmed.2016.08.007.","journal-title":"Trends Mol Med."},{"issue":"11","key":"2358_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.5966\/sctm.2015-0343","volume":"5","author":"PH Lee","year":"2016","unstructured":"Lee PH, Tu CT, Hsiao CC, Tsai MS, Ho CM, Cheng NC, et al. Antifibrotic activity of human placental amnion membrane-derived CD34+ mesenchymal stem\/progenitor cell transplantation in mice with thioacetamide-induced liver injury. Stem Cells Transl Med. 2016;5(11):1473\u201384. https:\/\/doi.org\/10.5966\/sctm.2015-0343.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"2358_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat M, Bobkov I, Kumar S, Grumet M. Trends in mesenchymal stem cell clinical trials 2004-2018: is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 2020;9(1):17\u201327. https:\/\/doi.org\/10.1002\/sctm.19-0202.","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"2358_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-018-1122-8","volume":"10","author":"XY Luo","year":"2019","unstructured":"Luo XY, Meng XJ, Cao DC, Wang W, Zhou K, Li L, et al. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes. Stem Cell Res Ther. 2019;10(1):16. https:\/\/doi.org\/10.1186\/s13287-018-1122-8.","journal-title":"Stem Cell Res Ther."},{"issue":"7","key":"2358_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.294","volume":"5","author":"J Moreno-C\u00e0ceres","year":"2014","unstructured":"Moreno-C\u00e0ceres J, Caja L, Mainez J, Mayoral R, Mart\u00edn-Sanz P, Moreno-Vicente R, et al. Caveolin-1 is required for TGF-\u03b2-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE\/ADAM17. Cell Death Dis. 2014;5(7):e1326. https:\/\/doi.org\/10.1038\/cddis.2014.294.","journal-title":"Cell Death Dis."},{"key":"2358_CR35","doi-asserted-by":"publisher","unstructured":"Lu J, Zhang J, Wang Y, Sun Q. Caveolin-1 scaffolding domain peptides alleviate liver fibrosis by inhibiting TGF-\u03b21\/Smad signaling in mice. Int J Mol Sci. 2018;19(6):1729. https:\/\/doi.org\/10.3390\/ijms19061729.","DOI":"10.3390\/ijms19061729"},{"issue":"6","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.matbio.2013.03.005","volume":"32","author":"D Gvaramia","year":"2013","unstructured":"Gvaramia D, Blaauboer ME, Hanemaaijer R, Everts V. Role of caveolin-1 in fibrotic diseases. Matrix Biol. 2013;32(6):307\u201315. https:\/\/doi.org\/10.1016\/j.matbio.2013.03.005.","journal-title":"Matrix Biol."},{"issue":"13","key":"2358_CR37","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2010.356","volume":"303","author":"J Moore","year":"2010","unstructured":"Moore J, McKnight AJ, Simmonds MJ, Courtney AE, Hanvesakul R, Brand OJ, et al. Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. Jama. 2010;303(13):1282\u20137. https:\/\/doi.org\/10.1001\/jama.2010.356.","journal-title":"Jama."},{"key":"2358_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2014.07.020","volume":"76","author":"P Shivshankar","year":"2014","unstructured":"Shivshankar P, Halade GV, Calhoun C, Escobar GP, Mehr AJ, Jimenez F, et al. Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction. J Mol Cell Cardiol. 2014;76:84\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.07.020.","journal-title":"J Mol Cell Cardiol."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02358-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T12:08:41Z","timestamp":1621512521000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02358-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human embryonic tissue was obtained according to procedures approved by the Medical Ethics Committee, Sichuan University (the registration number K-2018109-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}